Premature ovarian failure in the fragile X syndrome (Q34306135)

1 August 2017

1 reference

title

Premature ovarian failure in the fragile X syndrome (English)

1 reference

premature ovarian failure

1 August 2017

1 reference

1 reference

Sherman SL

1

1 reference

1 August 2017

1 January 2000

1 reference

American Journal of Medical Genetics Part A

1 August 2017

1 reference

1 August 2017

97

1 reference

1 August 2017

3

1 reference

1 August 2017

189-194

1 reference

Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.

1 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Premature ovarian failure: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Fragile X premutation screening in women with premature ovarian failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Quantitative comparison of FMR1 gene expression in normal and premutation alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

The female and the fragile X. A study of 144 obligate female carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Tissue-specific expression of a FMR1/beta-galactosidase fusion gene in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Fragile X premutations are not a major cause of early menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Association between idiopathic premature ovarian failure and fragile X premutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Reproductive and menstrual history of females with fragile X expansions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Studies of FRAXA and FRAXE in women with premature ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Obstetrical and gynecological complications in fragile X carriers: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Examination of factors that influence the expansion of the fragile X mutation in a sample of conceptuses from known carrier females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Dizygous twinning and premature menopause in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

Fragile X premutations in familial premature ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-8628%28200023%2997%3A3%3C189%3A%3AAID-AJMG1036%3E3.0.CO%3B2-J

10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11449487